Komori
ASKA Pharmaceutical Holdings (4886) · InitiativeFirst stated

Co-Promotion Agreement for an RSV Vaccine

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Co-Promotion Agreement for the RSV Vaccine AbrysvoA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「RSウイルスワクチン「アブリスボ®筋注用」 共同販促（コ・プロモーション）権の被許諾」

    ファイザー株式会社とのRSウイルスワクチン「アブリスボ」共同販促契約を初めて記載している。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.